Last updated on February 2020

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease


Brief description of study

The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.

Clinical Study Identifier: NCT03926130

Find a site near you

Start Over

City Hospital of Saint Martyr Elizabeth

Saint Petersburg, Russian Federation
  Connect »

LLC Gastroenterology Centre Expert

Saint-Petersburg, Russian Federation
3.39miles
  Connect »

SBIH City Clinical Hospital #31

Saint-Petersburg, Russian Federation
3.39miles
  Connect »

Pokrovskaya Municipal Hospital

Saint-Petersburg, Russian Federation
4.73miles
  Connect »

LLC Scientific Research Centre EKO-Bezopasnost

St. Petersburg, Russian Federation
6.12miles
  Connect »

LLC Medical Center Reavita Med SPb

Saint Petersburg,, Russian Federation
7.22miles
  Connect »